Literature DB >> 8139532

A constitutively activated erythropoietin receptor stimulates proliferation and contributes to transformation of multipotent, committed nonerythroid and erythroid progenitor cells.

G D Longmore1, P N Pharr, H F Lodish.   

Abstract

If the env gene of spleen focus-forming virus (SFFV) is replaced by a cDNA encoding a constitutively active form of the erythropoietin receptor, EPO-R(R129C), the resultant recombinant virus, SFFVcEPO-R, induces transient thrombocytosis and erythrocytosis in infected mice. Clonogenic progenitor cell assays of cells from the bone marrow and spleens of these infected mice suggest that EPO-R(R129C) can stimulate proliferation of committed megakaryocytic and erythroid progenitors as well as nonerythroid multipotent progenitors. From the spleens of SFFVcEPO-R-infected mice, eight multiphenotypic immortal cell lines were isolated and characterized. These included primitive erythroid, lymphoid, and monocytic cells. Some expressed proteins characteristic of more than one lineage. All cell lines resulting from SFFVcEPO-R infection contained a mutant form of the p53 gene. However, in contrast to infection by SFFV, activation of PU.1 gene expression, by retroviral integration, was not observed. One cell line had integrated a provirus upstream of the fli-1 gene, in a location typically seen in erythroleukemic cells generated by Friend murine leukemia virus infection. This event led to increased expression of fli-1 in this cell line. Thus, infection by SFFVcEPO-R can induce proliferation and lead to transformation of nonerythroid as well as very immature erythroid progenitor cells. The sites of proviral integration in clonal cell lines are distinct from those in SFFV-derived lines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139532      PMCID: PMC358593          DOI: 10.1128/mcb.14.4.2266-2277.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

Review 1.  Friend virus-induced erythroleukemia and the multistage nature of cancer.

Authors:  Y Ben-David; A Bernstein
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

2.  An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogene.

Authors:  G D Longmore; H F Lodish
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

3.  Monoclonal antibody to spleen focus-forming virus-encoded gp52 provides a probe for the amino-terminal region of retroviral envelope proteins that confers dual tropism and xenotropism.

Authors:  L Wolff; R Koller; S Ruscetti
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Heterogeneous metabolism and subcellular localization of a potentially leukemogenic membrane glycoprotein encoded by Friend erythroleukemia virus. Isolation of viral and cellular processing mutants.

Authors:  M Ruta; S Clarke; B Boswell; D Kabat
Journal:  J Biol Chem       Date:  1982-01-10       Impact factor: 5.157

6.  Quantitative colony method for tumorigenic cells transformed by two distinct strains of Friend leukemia virus.

Authors:  D L Mager; T W Mak; A Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

7.  Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1.

Authors:  Y Ben-David; E B Giddens; K Letwin; A Bernstein
Journal:  Genes Dev       Date:  1991-06       Impact factor: 11.361

Review 8.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

9.  Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis.

Authors:  O Miura; A D'Andrea; D Kabat; J N Ihle
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

10.  In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development.

Authors:  S Nishikawa; M Kusakabe; K Yoshinaga; M Ogawa; S Hayashi; T Kunisada; T Era; T Sakakura; S Nishikawa
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

View more
  13 in total

1.  Interaction between the glucocorticoid and erythropoietin receptors in human erythroid cells.

Authors:  Emilia Stellacci; Antonella Di Noia; Angela Di Baldassarre; Giovanni Migliaccio; Angela Battistini; Anna Rita Migliaccio
Journal:  Exp Hematol       Date:  2009-05       Impact factor: 3.084

2.  Erythropoietin receptors that signal through Stat5 or Stat3 support fetal liver and adult erythropoiesis: lack of specificity of stat signals during red blood cell development.

Authors:  S S Watowich; A Mikami; R A Busche; X Xie; P N Pharr; G D Longmore
Journal:  J Interferon Cytokine Res       Date:  2000-12       Impact factor: 2.607

3.  JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.

Authors:  Jiahai Shi; Bingbing Yuan; Wenqian Hu; Harvey Lodish
Journal:  Exp Hematol       Date:  2016-07-26       Impact factor: 3.084

4.  Oncogene cooperativity in Friend erythroleukemia: erythropoietin receptor activation by the env gene of SFFV leads to transcriptional upregulation of PU.1, independent of SFFV proviral insertion.

Authors:  Iva Afrikanova; Ellen Yeh; David Bartos; Stephanie S Watowich; Gregory D Longmore
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

Review 5.  The erythropoietin receptor: molecular structure and hematopoietic signaling pathways.

Authors:  Stephanie S Watowich
Journal:  J Investig Med       Date:  2011-10       Impact factor: 2.895

6.  Mimicry of erythropoietin by a nonpeptide molecule.

Authors:  S A Qureshi; R M Kim; Z Konteatis; D E Biazzo; H Motamedi; R Rodrigues; J A Boice; J R Calaycay; M A Bednarek; P Griffin; Y D Gao; K Chapman; D F Mark
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

7.  Absence of cytokine receptor-dependent specificity in red blood cell differentiation in vivo.

Authors:  M A Goldsmith; A Mikami; Y You; K D Liu; L Thomas; P Pharr; G D Longmore
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

8.  Constitutively active erythropoietin receptor expression in breast cancer cells promotes cellular proliferation and migration through a MAP-kinase dependent pathway.

Authors:  Ping Fu; Xiaohong Jiang; Murat O Arcasoy
Journal:  Biochem Biophys Res Commun       Date:  2009-01-06       Impact factor: 3.575

9.  Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice.

Authors:  Derya Sargin; Ahmed El-Kordi; Amit Agarwal; Michael Müller; Sonja M Wojcik; Imam Hassouna; Swetlana Sperling; Klaus-Armin Nave; Hannelore Ehrenreich
Journal:  BMC Biol       Date:  2011-04-28       Impact factor: 7.431

10.  The effect of erythropoietin on normal and neoplastic cells.

Authors:  Steve Elliott; Angus M Sinclair
Journal:  Biologics       Date:  2012-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.